APOA1 and familial pancreatic carcinoma: In another study, the authors [13] aimed to identify new biomarkers in pancreatic cancer patients; they reported that apoA concentrations were decreased at least 2-fold in pancreatic cancer patients (n = 96) compared with the control group (n = 96 healthy volunteers) [13].